Two Points of View on CBD for Coronavirus Therapy.admin
While Federal Agencies Continue Crackdown on Bogus COVID-19 Claims, Some Scientists Believe that Marijuana Terpenes Could Treat COVID-19.
Authors: Keller and Heckman LLP – Sheila A. Millar and Tracy P. Marshall
The COVID-19 pandemic has prompted regulatory agencies to take swift action against companies that falsely advertise their products as treatments for the virus.
As we previously reported, the Federal Trade Commission (FTC) and Food and Drug Administration (FDA) issued joint warning letters to seven companies in March for advertising and selling products or services that the agencies allegedly falsely claimed to lessen or prevent COVID-19, in violation of Section 5 of the FTC Act and the Food, Drug, and Cosmetic Act (FD&C Act).
That action was followed by a second set of similar warning letters from the FTC to another ten businesses on April 24, 2020 and a third set of warning letters to another 45 companies on May 7, 2020. The letters have been sent to a wide spectrum of businesses making unsupported claims related to COVID-19 therapies or treatments, including manufacturers of air purifiers/sanitizers and water filters, ozone therapy marketers, chiropractors, supplement manufacturers, and businesses offering stay-at-home work opportunities.
Author: Brendan Bures
Israeli researchers will utilize antiviral agents found in cannabis terpenes to slow the spread of the novel coronavirus. This is not the first research to investigate how terpenes impact a coronavirus. In a 2007 study, Chinese scientists found that different sets of terpenes reduced the severity and spread of the SARS coronavirus in-vitro and in-vivo — or, in both a laboratory petri dish and live organisms. The plant compounds blocked a specific protein that allows the virus to replicate itself throughout the body.
Israeli researchers plan to build upon that research and develop a novel terpene combination to use in COVID-19 treatment. Cannabis research company CannaSoul Analytics and Israeli entrepreneur Nadav Eyal will collaborate on the venture. Their formulation will be administered through direct inhalation.
“Our lab has been approved to operate as a corona lab, and in doing so, we are promoting 2 studies based on existing cannabis studies: First, we will try to identify the plant’s own molecules that are capable of suppressing the immune response to the COVID-19 coronavirus, which causes inflammation and severe disease,” Dedi Meiri, Cannasoul Chairman and Asst. Professor at the Israel Institute of Technology, said in a statement. “To lower the immune system response without suppressing it, thereby providing better complementary treatment to the steroids, which completely suppress the immune system.”
Other Israeli scientists have begun research into what role CBD could play in COVID-19 treatment. While Meiri and his team will explore terpenes as antiviral agents, the clinical trial will utilize CBD’s anti-inflammatory properties to reduce symptoms and regulate the body’s immune system.
Without sufficient high-quality evidence in human studies we cannot make claims or statements about CBD in COVID-19 therapy, and because CBD is currently is mostly available as an unregulated supplement, it’s difficult to know exactly what you are getting. If you decide to try CBD, talk with your doctor — if for no other reason than to make sure it will not affect other medications you are taking.